These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 8593796

  • 1. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA, Sánchez-Franco F, Lorenzo MJ, Pazos F, Lara JI, Cacicedo L.
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [Abstract] [Full Text] [Related]

  • 2. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
    Balsa JA, Cacicedo L, Lara JI, Lorenzo MJ, Pazos F, Sanchez-Franco F.
    Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
    [Abstract] [Full Text] [Related]

  • 3. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system.
    Lara JI, Lorenzo MJ, Cacicedo L, Tolón RM, Balsa JA, López-Fernández J, Sánchez-Franco F.
    Endocrinology; 1994 Dec; 135(6):2526-32. PubMed ID: 7988440
    [Abstract] [Full Text] [Related]

  • 4. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME.
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [Abstract] [Full Text] [Related]

  • 5. Sodium ions: their role and mechanism of action in the control of prolactin release.
    Collu R, Lafond J, Marchisio AM, Eljarmak D, Ducharme JR.
    Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
    [Abstract] [Full Text] [Related]

  • 6. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J, Cacicedo L, Ortego J, Melian E, Sánchez-Franco F.
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [Abstract] [Full Text] [Related]

  • 7. Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior and posterior pituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide.
    Balsa JA, Sánchez-Franco F, Pazos F, Lara JI, Lorenzo MJ, Maldonado G, Cacicedo L.
    Neuroendocrinology; 1998 Nov; 68(5):326-33. PubMed ID: 9822800
    [Abstract] [Full Text] [Related]

  • 8. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
    Pu HF, Liu TC.
    J Cell Biochem; 2002 Nov; 86(2):268-76. PubMed ID: 12111996
    [Abstract] [Full Text] [Related]

  • 9. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ, Samson WK.
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [Abstract] [Full Text] [Related]

  • 10. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
    Gómez O, Balsa JA.
    Neuroendocrinology; 2004 Feb; 80(5):324-31. PubMed ID: 15677882
    [Abstract] [Full Text] [Related]

  • 11. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G, Guthrie J, Weiner RI.
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide stimulates prolactin mRNA expression in turkey pituitary cells: effects of dopaminergic drugs.
    Xu M, Proudman JA, Pitts GR, Wong EA, Foster DN, el Halawani ME.
    Proc Soc Exp Biol Med; 1996 May; 212(1):52-62. PubMed ID: 8618952
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of prolactin secretion by dopamine and vasoactive intestinal peptide at the level of the pituitary in the turkey.
    Youngren OM, Chaiseha Y, El Halawani ME.
    Neuroendocrinology; 1998 Nov; 68(5):319-25. PubMed ID: 9822799
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of prolactin secretion after short term or pulsatile exposure to dopamine in superfused anterior pituitary cell aggregates.
    Denef C, Baes M, Schramme C.
    Endocrinology; 1984 Apr; 114(4):1371-8. PubMed ID: 6705740
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
    Wang J, Ciofi P, Crowley WR.
    Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
    [Abstract] [Full Text] [Related]

  • 18. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC, Chapman LP, Morris JF.
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [Abstract] [Full Text] [Related]

  • 19. The cortical actin cytoskeleton of lactotropes as an intracellular target for the control of prolactin secretion.
    Carbajal ME, Vitale ML.
    Endocrinology; 1997 Dec; 138(12):5374-84. PubMed ID: 9389523
    [Abstract] [Full Text] [Related]

  • 20. Regulation of prolactin gene expression by vasoactive intestinal peptide and dopamine in the turkey: role of Ca signalling.
    Al Kahtane A, Kannan M, Kang SW, El Halawani ME.
    J Neuroendocrinol; 2005 Oct; 17(10):649-55. PubMed ID: 16159377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.